Does Andrographis Help With Andrographis extract shows moderate evidence for reducing...?

Evidence Summary

Andrographis extract shows moderate evidence for reducing symptoms of upper respiratory tract infections (common cold, pharyngitis), with standardized extracts at 200-400 mg/day significantly lowering symptom scores compared to placebo by day 3 (PMID: 36842634), and a topical spray formulation reducing pharyngitis symptom duration faster than chamomile control (PMID: 37821383). It also demonstrates anti-inflammatory effects, significantly reducing IL-1β, IL-6, TNF-α, and hs-CRP in clinical settings (PMID: 37625206, 34532749). A phase II trial in esophageal cancer patients suggested potential palliative benefit and gut microbiota modulation, though the study was small and uncontrolled (PMID: 37042309).

Source: auto-research

Effective Dose

200-400 mg/day standardized extract for upper respiratory infections based on clinical trials